Pazopanib

Pazopanib is a targeted therapy medication used to treat advanced renal cell carcinoma, a type of kidney cancer. It works by inhibiting multiple tyrosine kinase enzymes, which are involved in the growth and spread of cancer cells. By blocking these enzymes, Pazopanib can slow down the progression of the disease and help to control symptoms.
Pazopanib is typically prescribed for patients whose cancer has progressed after other treatments, such as surgery, radiation, or other medications. It is taken orally, once daily, and is available in tablet form. The medication should be taken with food to reduce the risk of stomach upset.
Some common side effects of Pazopanib include high blood pressure, nausea, diarrhea, hair loss, and skin reactions. Patients should have their blood pressure monitored regularly while taking this medication, as high blood pressure is a common side effect that requires treatment.
Pazopanib is not suitable for everyone, and patients should discuss the potential benefits and risks with their healthcare provider before starting treatment. It is important to report any side effects or changes in health to the healthcare provider, as adjustments to the dosage or treatment plan may be necessary.